Delivery Order SPE2DB20D2104-SPE2DB25FMGRZ

Award Date 1/27/25
Potential Completion Date 1/28/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting, with a ceiling value of $1,849.42 and a completion date of February 4, 2025. The contract is structured as a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $2,586.96 and a completion date of January 21, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,560,394 units of Ondansetron ODT 4 mg tablets, which are used to treat nausea and vomiting. The fixed-price contract has a ceiling value of $3,093.30 and a period of performance through March 28, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting, with a ceiling value of $16,018.88 and a completion date of February 11, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $14,705.37 and runs through April 26, 2023. The contract is a firm-fixed-price delivery order and was not set aside for any specific business size or socioeconomic...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $5,962.53. The contract is for the supply of Ondansetron ODT 8 mg tablets, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of January 23, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Ondansetron ODT 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $4,988.22 and an ultimate completion date of August 1, 2024. The contract is a firm fixed-price type and does not have a set-aside designation. Amerisourcebergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $12,896.42 and runs through February 4, 2025. It is a firm fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,296,427 units of Ondansetron ODT 4 MG tablets, a medication used to treat nausea and vomiting. The contract has a firm fixed price of $15,175.16 and a performance period ending on July 31, 2024. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $34,216.36 and is a firm fixed-price contract with a completion date of January 25, 2024. The contract was not set aside for any specific business category. AmerisourceBergen holds a larger Indefinite...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMGRZ
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting, with a ceiling value of $1,603.95 and a completion date of January 28, 2025.

The contract is not designated as a set-aside and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order falls under the broader scope of that IDC.

Generated 4/28/25, 9:49 AM